PQQ is a redox cofactor, found in various foods such as kiwifruit, green peppers, and fermented soybeans. It serves as a potent antioxidant, protecting cells from oxidative stress—a leading cause of cellular damage and aging. One of PQQ’s most remarkable functions is its ability to stimulate the growth of new mitochondria, the powerhouses of our cells. This process, known as mitochondrial biogenesis, can lead to enhanced energy metabolism, improved cognitive function, and increased resilience against cellular aging.
The development process begins with drug discovery, focusing on identifying potential candidates that can effectively target specific biological pathways. During this phase, researchers explore various chemical entities to assess their activity against disease models. Once promising candidates emerge, they advance into preclinical studies, where APIs undergo rigorous testing for pharmacokinetics, pharmacodynamics, and toxicity. These studies ensure that selected APIs have the potential for success in clinical trials.
api drug development
Another significant advantage is its rich history of use, allowing anesthesiologists to develop a strong understanding of its pharmacokinetics and safety profile. This extensive experience contributes to the predictability of its effects during surgery, establishing it as a reliable option for various surgical procedures, from minor outpatient surgeries to major operations.